Viewing nowDapagren Tablets 10 Milligrams (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

MFDS item code 202300420 · Approved 2023.01.31 · Insurance code 650304460
Improves blood glucose control in type 2 diabetes mellitus; reduces the risk of progression of chronic kidney disease and death
This medication is used as an adjunct to diet and exercise in the management of blood sugar levels in patients with type 2 diabetes. It should be used with caution in patients with cardiovascular diseases or risk factors. Furthermore, it helps reduce the risk associated with renal function decline in patients with chronic kidney disease and decreases the risk of cardiovascular disease and renal-related mortality. Therefore, this medication is effectively used in the treatment of both type 2 diabetes and chronic kidney disease.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received pharmacological treatment for diabetes, when administered in combination with metformin, the recommended initial dose of this drug is 5mg once daily or 10mg once daily. Chronic kidney disease The recommended dose of this drug is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Administration of this drug to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this drug is not recommended in patients with chronic kidney disease. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is required for patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Under 18 years of age: The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be administered to certain patients. For example, patients with allergies to the active ingredient or additives of this medication, patients with type 1 diabetes, patients with diabetic ketoacidosis, and those with lactose intolerance or related genetic problems should not take this medication. Patients undergoing dialysis should also avoid using this medication. Patients with reduced fluid volume or kidney function issues should use this medication with caution. This medication can cause hypotension and worsen kidney function, so fluid status and kidney function should be monitored carefully before administration and continuously during treatment. Special care should be taken for the elderly or patients on diuretics as they have a higher risk of hypotension. During use of this medication, side effects such as genital infections, urinary tract infections, hypoglycemia, reduced fluid volume, and diabetic ketoacidosis may occur. Genital infections and urinary tract infections may be more common in women and patients with a history of previous infections; immediate treatment should be sought if symptoms develop. Hypoglycemia may occur more frequently when taken with medications like insulin or sulfonylureas, so dosage adjustments for these medications may be necessary. Additionally, this medication may have weight loss effects, and in rare cases, serious infections such as severe perineal necrosis may occur, so if any pain, swelling, or redness appears around the genital area, medical consultation should be sought immediately. Pregnant women should not use this medication, and if pregnancy is confirmed, administration should be stopped. It is also recommended that breastfeeding women do not take this medication. This medication can interact with other drugs, so especially when taken with diuretics, insulin, or sulfonylureas, discussions with healthcare professionals regarding appropriate dosage adjustments are necessary. Lastly, glucose may be detected in urine tests while on this medication, so this should be noted when interpreting test results. There is no special caution needed while driving or operating machinery, but awareness of hypoglycemic symptoms is essential.
Vulvovaginitis, balanitis and related genital infections, urinary tract infection, fungal infection, perineal necrosis, hypoglycemia, decreased fluid volume, polydipsia, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, vulvar itching, genital itching, increased hematocrit, initial decrease in renal creatinine clearance during treatment, dyslipidemia, initial increase in serum creatinine during treatment, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, hyperglycemia, paresthesia, cerebral infarction, nerve compression, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, intracerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, biliary stones, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, chronic gastritis, diverticulitis, pneumoperitoneum, frequent bowel movements, gastroenteritis, colorectal polyps, intestinal perforation, epigastric discomfort, functional dyspepsia, erosive gastritis, gum disease, gum pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, chronic pancreatitis, urgency, diabetic nephropathy, overactive bladder, microalbuminuria, stress urinary incontinence, urinary hesitancy, urinary stones, abnormal urination, increased blood lactate, lymphocytopenia, weight gain, decreased appetite, next syndrome, dysgeusia, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremor, bronchitis, shingles, sinusitis, tonsillitis, herpes simplex, hordeolum, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, influenza-like syndrome, chest pain, fatigue, pain, peripheral edema, generalized edema, hunger, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort during menstruation, irregular menstruation, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcer, hyperhidrosis eczema, coin eczema, eczema, hyperkeratosis, nail pigmentation, skin lesion, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to keep the storage temperature between 1 degree and 30 degrees Celsius at room temperature. This will help to safely maintain the medication's effectiveness.
Yellow diamond-shaped film-coated tablets
Box - 28 tablets/box [(14 tablets/PTP (Alu-Alu) x 2)], Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.